Recent papers have demonstrated that the MICA A5.1 polymorphism modulates cancer susceptibility in several cancer types including cervical cancer[20], oral squamous cell carcinoma[21–23] and hepatocellular carcinoma[24–26]. The gene discussed is MICA; the disease is hepatocellular carcinoma.